Sol-Gel Technologies Ltd. (SLGL)
NASDAQ: SLGL · Real-Time Price · USD
77.92
-6.82 (-8.05%)
Aug 11, 2026, 4:00 PM EDT - Market closed
Sol-Gel Technologies Market Cap
Sol-Gel Technologies has a market cap or net worth of $254.72 million as of August 12, 2026. Its market cap has increased by 472.40% in one year.
Market Cap
254.72M
Enterprise Value
202.75M
1-Year Change
472.40%
Ranking
Category
Stock Price
$77.92
ChartMarket Cap Chart
Since February 1, 2018, Sol-Gel Technologies's market cap has increased from $228.30M to $254.72M, an increase of 11.57%. That is a compound annual growth rate of 1.29%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 11, 2026 | 254.70M | 116.95% |
| Dec 31, 2025 | 117.40M | 353.28% |
| Dec 31, 2024 | 25.90M | -15.91% |
| Dec 29, 2023 | 30.80M | -70.81% |
| Dec 30, 2022 | 105.50M | -38.34% |
| Dec 31, 2021 | 171.10M | -24.02% |
| Dec 31, 2020 | 225.20M | -35.58% |
| Dec 31, 2019 | 349.60M | 206.94% |
| Dec 31, 2018 | 113.90M | -50.11% |
| Feb 1, 2018 | 228.30M | - |
View and export this data all the way back to 2018. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Surrozen | 296.95M |
| Vanda Pharmaceuticals | 296.27M |
| Immuneering | 294.70M |
| Neumora Therapeutics | 293.68M |
| Turn Therapeutics | 291.92M |
| Zentalis Pharmaceuticals | 290.27M |
| Lineage Cell Therapeutics | 287.05M |
| Fulcrum Therapeutics | 286.88M |